OC
MXL icon

Oppenheimer & Co’s MaxLinear MXL Stock Holding History

Oppenheimer & Co’s Portfolio MXL Stock Details MXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-9,025
Closed -$253K – 1336
2017
Q1 		$253K Buy
+9,025
New +$231K 0.01% 1065
2016
Q2 		– Sell
-10,373
Closed -$192K – 1279
2016
Q1 		$192K Buy
+10,373
New +$165K 0.01% 1108

Other funds holding MXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Oppenheimer & Co's MXL Position: Q2 2017 in Review

Oppenheimer & Co sold out of MaxLinear (MXL) in Q2 2017, closing a stake of 9,025 shares — an estimated $253K sold.

Oppenheimer & Co first reported a position in MXL in Q1 2016 and held it in 2 quarters. The position peaked at $253K in Q1 2017. 199 funds tracked by Wall St. Rank hold MXL as of Q2 2017.

  • Oppenheimer & Co reported no remaining MaxLinear position as of Q2 2017 after selling out during the quarter.
  • Oppenheimer & Co sold 9,025 MaxLinear shares in Q2 2017, an estimated $253K.
  • Oppenheimer & Co first reported a position in MaxLinear in Q1 2016 and held it in 2 quarters.
  • Oppenheimer & Co's MaxLinear position peaked at $253K in Q1 2017.
  • 199 funds tracked by Wall St. Rank held MaxLinear as of Q2 2017.

Based on Oppenheimer & Co's 13F filing for Q2 2017, filed 9 Aug 2017.